Effect of hypertonic saline, amiloride, and cough on mucociliary clearance in patients with cystic fibrosis

American Journal of Respiratory and Critical Care Medicine

Volumn 153, Issue 5, 1996, Pages 1503-1509

  Robinson, Michael ^d   Regnis, Jeffrey A ^a   Bailey, Dale L ^b   King, Malcolm ^d   Bautovich, George J ^d   Bye, Peter T P ^c  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMILORIDE; HYPERTONIC SOLUTION; SODIUM CHLORIDE;

ADULT; AEROSOL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; COUGHING; CYSTIC FIBROSIS; DRUG EFFECT; DRUG THERAPY; FEMALE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG DISEASE; MALE; MUCOCILIARY CLEARANCE; PHARMACOLOGY; PRIORITY JOURNAL;

EID: 0029916071     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.153.5.8630593     Document Type: Article

References (33)

1. Yeates, D. B., J. M. Sturgess, S. R. Kahn, H. Levison, and N. Aspin. 1976. Mucociliary transport in the trachea of patients with cystic fibrosis. Arch. Dis. Child. 51:28-33.
2. Matthys, H., and D. Kohler. 1986. Bronchial clearance in cystic fibrosis. Eur. J. Respir. Dis. 69(Suppl. 146):311-318.
3. Regnis, J. A., M. Robinson, D. L. Bailey, P. Cook, P. Hooper, H.-K. Chan, I. Gonda, G. Bautovich, and P. T. P. Bye. 1994. Mucociliary clearance in patients with cystic fibrosis and in normal subjects. Am. J. Respir. Crit. Care Med. 150:66-71.
4. Potter, J. L., L. W. Matthews, S. Spector, and J. Lemm. 1967. Studies on pulmonary secretions II. Osmolality and the ionic environment of pulmonary secretions from patients with cystic fibrosis, bronchiectasis and laryngectomy. Am. Rev. Respir. Dis. 96:83-87.
5. Pavia, D., M. L. Thomson, and S. W. Clarke. 1978. Enhanced clearance of secretions from the human lung after the administration of hypertonic saline aerosol. Am. Rev. Respir. Dis. 117:199-203.
6. Knowles, M. R., J. T. Gatzy, and R. C. Boucher. 1981. Increased bioelectric potential difference across respiratory epithelia in cystic fibrosis. N. Engl. J. Med. 305:1489-1495.
7. + transport in cystic fibrosis respiratory epithelia: abnormal basal rate and response to adenylate cyclase activation. J. Clin. Invest. 78:1245-1252.
8. Knowles, M. R., N. L. Church, W. E. Waltner, J. R. Yankaskas, P. Gilligan, M. King, L. J. Edwards, R. W. Helms, and R. C. Boucher. 1990. A pilot study of aerosolized amiloride for the treatment of lung disease in cystic fibrosis. N. Engl. J. Med. 322:1189-1194.
9. App, E. M., M. King, R. Helfesrieder, D. Kohler, and H. Matthys. 1990. Acute and long-term amiloride inhalation in cystic fibrosis lung disease. Am. Rev. Respir. Dis. 141:605-612.
10. Phipps, P. R., I. Gonda, and S. D. Anderson. 1992. Apparatus for the control of breathing patterns during aerosol inhalation. J. Aerosol Med. 5:155-170.
11. Mentz, W. M., J. B. Brown, M. Friedman, M. J. Stutts, J. T. Gatzy, and R. C. Boucher. 1986. Deposition, clearance and effects of aerosolized amiloride in sheep airways. Am. Rev. Respir. Dis. 134:938-943.
12. Curtis, L. N., and D. W. Misch. 1984. Regulation of mucociliary transport: response of mucous cells to stimulation by amiloride applied to the frog palate in vitro. Am. Rev. Respir. Dis. 129:818-822.
13. Schoeffel, R. E., S. D. Anderson, and R. E. Altounyan. 1981. Bronchial hyperreactivity in response to inhalation of ultrasonically nebulised solutions of distilled water and saline. B.M.J. 283:1285-1287.
14. Bailey, D. L., R. R. Fulton, C. B. Jackson, B. F. Hutton, and J. G. Morris. 1989. Mean studies using a single headed rotating gamma camera. J. Nucl. Med. 30:1865-1869.
15. Altman, D. G. 1992. Practical Statistics for Medical Research. Chapman & Hall, London. 210-212, 325-351.
16. Boucher, R. C. 1994. Human airway ion transport. Am. J. Respir. Crit. Care Med. 150:581-593.
17. Assouline, G., V. Leibson, and A. Danon. 1977. Stimulation of prostaglandin output from rat stomach by hypertonic solutions. Eur. J. Pharmacol. 44:271-273.
18. Wanner, A., M. Sielczak, J. F. Mella, and W. M. Abraham. 1986. Ciliary responsiveness in allergic and nonallergic airways. J. Appl. Physiol. 60:1967-1971.
19. Boat, T. F., P. W. Cheng, and M. W. Leigh. 1994. Biochemistry of mucus. In T. Takashima and S. Sanae, editors. Airway Secretion: Physiological Bases for the Control of Mucus Hypersecretion (Lung Biology in Health and Disease Series). Marcel Dekker, New York. 217-282.
20. Shankar, V., B. Naziruddin, S. R. de la Rocha, and G. P. Sachdev. 1990. Evidence of hydrophobic domains in human respiratory mucins: effect of sodium chloride on hydrophobic binding properties. Biochemistry 29:5856-5864.
21. King, M., and A. Eisenberg. 1972. Viscoelastic properties of polyelectrolyte solutions at high concentrations. Am. Chem. Soc. Org. Coatings Plast. Chem. 32:327-335.
22. Lutz, R. J., M. Litt, and L. W. Chakrin. 1973. Physical-chemical factors in mucus rheology. In H. L. Gabelnick and M. Litt, editors. Rheology of Biological Systems. Charles C. Thomas, Springfield, IL. 158-194.
23. McCullagh, C. M., A. M. Jamieson, J. Blackwell, and R. Gupta. 1995. Viscoelastic properties of human tracheobronchial mucin in aqueous solution. Biopolymers 35:149-159.
24. Slayter, H. S., G. Lamblin, A. Le Treut, C. Galabert, N. Houdret, P. Degand, and P. Roussel. 1984. Complex structure of human bronchial mucus glycoprotein. Eur. J. Biochem. 142:209-218.
25. Chace, K. V., B. Naziruddin, V. C. Desai, M. Flux, and G. P. Sachdev. 1989. Physical properties of purified human respiratory mucus glycoproteins: effects of sodium chloride concentrations on the aggregation properties and shape. Exp. Lung Res. 15:721-737.
26. Scheffner, A. L., E. M. Medler, L. W. Jacobs, and H. P. Sarett. 1964. The in virto reduction in viscosity of human tracheobronchial secretions by acetylcysteine. Am. Rev. Respir. Dis. 90:721-729.
27. Lieberman, J., and N. B. Kurnick. 1962. Influence of deoxyribonucleic acid content on the proteolysis of sputum and pus. Nature (Lond.) 196:988-990.
28. Wills, P. J., and P. J. Cole. 1994. Hypertonic saline increases the ciliary transportability of bronchiectatic sputum (abstract). Am. Rev. Respir. Dis. 149:A119.
29. Tomkiewicz, R. P., E. M. App, J. G. Zayas, O. Ramirez, N. Church, R. C. Boucher, M. R. Knowles, and M. King. 1993. Amiloride inhalation therapy in cystic fibrosis. Influence on ion content, hydration and rheology of sputum. Am. Rev. Respir. Dis. 148:1002-1007.
30. Mortensen, J., M. Falk, S. Groth, and C. Jensen. 1991. The effects of postural drainage and positive expiratory pressure physiotherapy on tracheobronchial clearance in cystic fibrosis. Chest 100:1350-1357.
31. Rodwell, L. T., S. D. Anderson, J. du Toit, and P. Seale. 1992. Nedocromil sodium inhibits the airway response to hyperosmolar challenge in patients with asthma. Am. Rev. Respir. Dis. 146:1149-1155.
32. Rodwell, L. T., and S. D. Anderson. 1994. Hyperosmolar saline aerosol challenge: a useful tool in the management of subjects with cystic fibrosis (abstract). Aust. N.Z. J. Med. 484.
33. 2-adrenergic agonists on lung mucociliary clearance in patients with cystic fibrosis. Chest 103:805-811.